Additionally, more direct experimental support than that presented is still needed to determine whether the NF-κB pathway is involved in the mechanism of the ceRNA networks leading to OSA, and whether sub-immunocytes are changed in the OSA patients. This evidence concerns the gene NFKB1 and obstructive sleep apnea syndrome.